Skip to main content

Advertisement

Log in

Managing hypertension among nursing-home residents and community-dwelling elderly in Germany: a comparative pharmacoepidemiological study

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to investigate the adequacy of hypertension management in hypertensive elderly living in long-term-care facilities compared with home-living elderly.

Methods

This retrospective, cross-sectional, pharmacoepidemiological study compared data from a community-dwelling population (CD) and from four nursing homes (NH) in Dresden, Germany. Individuals aged ≥65 with the diagnosis of arterial hypertension were included. Demographical, medical, and drug prescription data as well as blood pressure (BP) values were analyzed and compared descriptively after matching the populations by age and gender.

Results

Each population comprised 209 patients (mean age 80.4 years [±6], 70.3% women). NH showed a higher number of diseases [7 (5–9) vs. 5 (3–7); p < 0.001]. BP (<140/90 mmHg) was better controlled in NH (61.0% vs. 48.1%; p = 0.015). The median number of BP-lowering drugs was three (2–4; CD) and two (1–3; NH) (range: 0–9). Most frequently used antihypertensives were diuretics and beta-blockers. Among renin–angiotensin system (RAS) blockers, angiotensin-receptor blockers (ARBs) were preferred in CD and angiotensin-converting enzyme (ACE) inhibitors in NH. Drug treatment for secondary prevention of myocardial infarction or stroke [acetylsalicylic acid (ASA) 100, RAS-blocker, beta-blocker, statin] was low among both groups (CD 21.3%; NH 1.6%; p = 0.01). NH received more inappropriate drugs, especially tranquillizers (31.2% vs. 21.0%; p < 0.05) [according to the PRISCUS (Latin for “old and venerable”) list for potentially inappropriate medications in the elderly (PIM)].

Conclusions

NH residents showed better BP control than CD elderly while receiving less antihypertensive drugs. The prescription of antihypertensives was assumed to be more cost effective in NH. Nevertheless, inappropriate drug use is still high (NH > CD), and there is an extended need for professional medication assessment in both groups of elderly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903–1913. doi:10.1016/S0140-6736(02)11911-8

    Article  PubMed  Google Scholar 

  2. Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O’Connor GT, Buring JE, Hennekens CH (1992) The primary prevention of myocardial infarction. N Engl J Med 326(21):1406–1416

    Article  PubMed  CAS  Google Scholar 

  3. Straus SE, Majumdar SR, McAlister FA (2002) New evidence for stroke prevention: scientific review. Jama 288(11):1388–1395. doi:10.1001/jama.288.11.1388

    Article  PubMed  Google Scholar 

  4. Whitworth JA (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21(11):1983–1992

    Article  PubMed  Google Scholar 

  5. Logan AG (2011) Hypertension in aging patients. Expert Rev Cardiovasc Ther 9(1):113–120. doi:10.1586/erc.10.171

    Article  PubMed  Google Scholar 

  6. Herrlinger C, Klotz U (2001) Drug metabolism and drug interactions in the elderly. Best Pract Res Clin Gastroenterol 15(6):897–918. doi:10.1053/bega.2001.0249

    Article  PubMed  CAS  Google Scholar 

  7. Bolbrinker J, Schedensack G, Kolzsch M, Breckwoldt J, Arntz HR, Kreutz R (2009) Antihypertensive drug treatment and renal function in geriatric emergency patients. Dtsch Med Wochenschr 134(16):802–806. doi:10.1055/s-0029-1220233

    Article  PubMed  CAS  Google Scholar 

  8. Tulner LR, Frankfort SV, Gijsen GJ, van Campen JP, Koks CH, Beijnen JH (2008) Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 25(4):343–355

    Article  PubMed  Google Scholar 

  9. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. Jama 294(6):716–724. doi:10.1001/jama.294.6.716

    Article  PubMed  CAS  Google Scholar 

  10. Kreutz R (2009) Special features of pharmacotherapy in older hypertensive subjects. Internist (Berl). doi:10.1007/s00108-008-2293-7

  11. McDonald M, Hertz RP, Unger AN, Lustik MB (2009) Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. J Gerontol A Biol Sci Med Sci 64(2):256–263. doi:10.1093/gerona/gln016

    Article  PubMed  Google Scholar 

  12. Muller A, Schweizer J, Kirch W, Schindler C (2010) Current status of antihypertensive drug treatment in primary care practice at launch of the new renin inhibitor aliskiren (RASANT). Med Klin (Munich) 105(3):155–162. doi:10.1007/s00063-010-1025-7

    Article  Google Scholar 

  13. Peron EP, Marcum ZA, Boyce R, Hanlon JT, Handler SM (2011) Year in review: medication mishaps in the elderly. Am J Geriatr Pharmacother 9(1):1–10. doi:10.1016/j.amjopharm.2011.01.003

    Article  PubMed  Google Scholar 

  14. Uhrhan T, Schaefer M (2010) Drug supply and patient safety in long-term care facilities for the elderly. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 53(5):451–459. doi:10.1007/s00103-010-1053-8

    Article  PubMed  CAS  Google Scholar 

  15. Kolzsch M, Bolbrinker J, Drager D, Scholze J, Huber M, Kreutz R (2010) Prescribing of antihypertensive drugs to elderly residents of nursing homes in Germany. Dtsch Med Wochenschr 135(48):2400–2405. doi:10.1055/s-0030-1269407

    Article  PubMed  CAS  Google Scholar 

  16. Stergiou GS, Bliziotis IA (2011) Home Blood Pressure Monitoring in the Diagnosis and Treatment of Hypertension: A Systematic Review. Am J Hypertens 24:123–134. doi:10.1038/ajh.2010.194

    Article  PubMed  Google Scholar 

  17. World Health Organisation, Collaborating Centre for Drug Statistics Methodology (2011) ATC Index with DDDs. Oslo

  18. Fulton MM, Allen ER (2005) Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 17(4):123–132. doi:10.1111/j.1041-2972.2005.0020.x

    Article  PubMed  Google Scholar 

  19. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L (2011) Aging with multimorbidity: A systematic review of the literature. Ageing Res Rev Epub ahead of print. doi:10.1016/j.arr.2011.03.003

  20. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23(5):469–480. doi:10.1111/j.1464-5491.2006.01858.x

    Article  PubMed  CAS  Google Scholar 

  21. World Health Organisation (March 2011) Obesity and overweight. WHO Fact sheet N°311. Accessed 28/04 2011

  22. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O’Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25(6):1105–1187. doi:10.1093/eurheartj/ehm236

    Article  PubMed  CAS  Google Scholar 

  23. Wald NJ, Law MR (2003) A strategy to reduce cardiovascular disease by more than 80%. Bmj 326(7404):1419. doi:10.1136/bmj.326.7404.1419

    Article  PubMed  CAS  Google Scholar 

  24. Holt S, Schmiedl S, Thürmann PA (2010) Potentially Inappropriate Medications in the Elderly: The PRISCUS List. Dtsch Arztebl Int 107(31–32):543–551. doi:10.3238/arztebl.2010.0543

    PubMed  Google Scholar 

  25. Sharma AM, Wittchen HU, Kirch W, Pittrow D, Ritz E, Goke B, Lehnert H, Tschope D, Krause P, Hofler M, Pfister H, Bramlage P, Unger T (2004) High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 22(3):479–486

    Article  PubMed  CAS  Google Scholar 

  26. Pittrow D, Kirch W, Bramlage P, Lehnert H, Hofler M, Unger T, Sharma AM, Wittchen HU (2004) Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol 60(2):135–142. doi:10.1007/s00228-004-0731-6

    Article  PubMed  CAS  Google Scholar 

  27. Tsuyuki RT, McLean DL, McAlister FA (2008) Management of hypertension in elderly long-term care residents. Can J Cardiol 24(12):912–914. doi:10.1016/S0828-282X(08)70698-6

    Article  PubMed  Google Scholar 

  28. Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM (2008) The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract 62(1):76–87. doi:10.1111/j.1742-1241.2007.01630.x

    Article  PubMed  CAS  Google Scholar 

  29. Ho PM, Bryson CL, Rumsfeld JS (2009) Medication adherence: its importance in cardiovascular outcomes. Circulation 119(23):3028–3035. doi:10.1161/CIRCULATIONAHA.108.768986

    Article  PubMed  Google Scholar 

  30. Elliott WJ (2009) Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens (Greenwich) 11(7):376–382. doi:10.1111/j.1751-7176.2009.00138.x

    Article  CAS  Google Scholar 

  31. Schwabe U, Pfaffrath D (2010) Arzneiverordnungs-Report 2010. Springer Berlin Heidelberg

  32. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358(15):1547–1559. doi:10.1056/NEJMoa0801317

    Article  PubMed  CAS  Google Scholar 

  33. Schindler C (2008) ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist’s perspective after publication of the results of ONTARGET. Ther Adv Cardiovasc Dis 2(4):233–248. doi:10.1177/1753944708094309

    Article  PubMed  Google Scholar 

  34. Laux G, Szecsenyi J, Miksch A, Grun B, Gutscher A, Grun B, Rosemann T, Kuhlein T (2009) Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance. Med Klin (Munich) 104(2):108–113. doi:10.1007/s00063-009-1028-4

    Article  Google Scholar 

  35. Baumgart P (1993) Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc Drugs Ther 7(Suppl 1):63–68

    Article  PubMed  Google Scholar 

  36. Wargo KA, Banta WM (2009) A comprehensive review of the loop diuretics: should furosemide be first line? Ann Pharmacother 43(11):1836–1847. doi:10.1345/aph.1M177

    Article  PubMed  CAS  Google Scholar 

  37. Luppa M, Luck T, Matschinger H, Konig HH, Riedel-Heller SG (2010) Predictors of nursing home admission of individuals without a dementia diagnosis before admission - results from the Leipzig Longitudinal Study of the Aged (LEILA 75+). BMC Health Serv Res 10(1):186. doi:10.1186/1472-6963-10-186

    Article  PubMed  Google Scholar 

  38. Coll-Planas L, Bergmann A, Schwarz P, Guillen-Grima F, Schulze J (2007) Quality of care among older adults with diabetes mellitus: comparison between community-dwelling adults attended to by home care services and nursing home residents in Dresden. Z Arztl Fortbild Qualitatssich 101(9):623–629. doi:10.1016/j.zgesun.2007.09.023

    PubMed  Google Scholar 

  39. Hochdruckliga D, e.V. (2009) Leitlinien zur Behandlung der arteriellen Hypertonie. Nieren- und Hochdruckkrankheiten 38:137–188

    Google Scholar 

  40. Deutsche Hochdruckliga e.V. Kommission Diabetes Goal blood pressure in patients with diabetes (Report) from 2010 Sept 7.

  41. Raum E, Lietzau S, Stegmaier C, Brenner H, Rothenbacher D (2008) For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany. Pharmacoepidemiol Drug Saf 17(5):485–494

    Article  PubMed  Google Scholar 

  42. Steinhagen-Thiessen E, Bramlage P, Losch C, Hauner H, Schunkert H, Vogt A, Wasem J, Jockel KH, Moebus S (2008) Dyslipidemia in primary care–prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 7:31

    Article  PubMed  Google Scholar 

  43. Shanmugasundaram M, Rough SJ, Alpert JS (2010) Dyslipidemia in the elderly: should it be treated? Clin Cardiol 33(1):4–9

    Article  PubMed  Google Scholar 

  44. Bohler S, Scharnagl H, Freisinger F, Stojakovic T, Glaesmer H, Klotsche J, Pieper L, Pittrow D, Kirch W, Schneider H, Stalla GK, Lehnert H, Zeiher AM, Silber S, Koch U, Ruf G, Marz W, Wittchen HU (2007) Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany. Atherosclerosis 190(2):397–407

    Article  PubMed  CAS  Google Scholar 

  45. Parikh S, Shrank WH, Mogun H, Choudhry NK (2010) Statin utilization in nursing home patients after cardiac hospitalization. J Gen Intern Med 25(12):1293–1299

    Article  PubMed  Google Scholar 

  46. Forman DE, Rich MW, Alexander KP, Zieman S, Maurer MS, Najjar SS, Cleveland JC Jr, Krumholz HM, Wenger NK (2011) Cardiac care for older adults. Time for a new paradigm. J Am Coll Cardiol 57(18):1801–1810

    Article  PubMed  Google Scholar 

  47. Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, Schroll M, Onder G, Sorbye LW, Wagner C, Reissigova J, Bernabei R (2005) Potentially inappropriate medication use among elderly home care patients in Europe. Jama 293(11):1348–1358

    Article  PubMed  CAS  Google Scholar 

  48. Lampela P, Hartikainen S, Lavikainen P, Sulkava R, Huupponen R (2010) Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study. Drugs Aging 27(6):507–521

    Article  PubMed  Google Scholar 

  49. Siegrist J, Shackelton R, Link C, Marceau L, von dem Knesebeck O, McKinlay J (2010) Work stress of primary care physicians in the US, UK and German health care systems. Soc Sci Med 71(2):298–304

    Article  PubMed  Google Scholar 

  50. Abteilung Gesundheit der VDEK (2011) Datenbestand Transparenzberichte in der DatenClearingStelle (5 Sept 2011). http://www.vdek.com/vertragspartner/Pflegeversicherung/Newsletter_Pflegenoten/DCS_2011-09-05.pdf. Accessed 8 Oct 2011.

  51. Fahey T, Montgomery AA, Barnes J, Protheroe J (2003) Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study. Bmj 326(7389):580

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sophie Lochner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lochner, S., Kirch, W. & Schindler, C. Managing hypertension among nursing-home residents and community-dwelling elderly in Germany: a comparative pharmacoepidemiological study. Eur J Clin Pharmacol 68, 867–875 (2012). https://doi.org/10.1007/s00228-011-1195-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-011-1195-0

Keywords

Navigation